Compounds > 1,2-dipalmitoylphosphatidylcholine
Page last updated: 2024-08-17

1,2-dipalmitoylphosphatidylcholine and 2019 Novel Coronavirus Disease

1,2-dipalmitoylphosphatidylcholine has been researched along with 2019 Novel Coronavirus Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Benfield, T; Berg, RMG; Nielsen, HB; Plovsing, RR; Ronit, A; Schousboe, P; Scoutaris, N; Verder, H; Verder, P; Wiese, L1
Wang, J; Wang, X; Wang, Z1

Other Studies

2 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and 2019 Novel Coronavirus Disease

ArticleYear
Reduced levels of pulmonary surfactant in COVID-19 ARDS.
    Scientific reports, 2022, 03-08, Volume: 12, Issue:1

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Adult; Aged; Bronchoalveolar Lavage Fluid; Case-Control Studies; COVID-19; Female; Humans; Male; Middle Aged; Principal Component Analysis; Pulmonary Surfactants; SARS-CoV-2; Severity of Illness Index; Spectrophotometry, Infrared

2022
Effect of Amphotericin B on the Thermodynamic Properties and Surface Morphology of the Pulmonary Surfactant Model Monolayer during Respiration.
    Molecules (Basel, Switzerland), 2023, Jun-18, Volume: 28, Issue:12

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Amphotericin B; COVID-19; Humans; Pandemics; Pulmonary Surfactants; Respiration; Surface Properties

2023